Clinical trial
Selective C-Reactive Protein Apheresis in Cardiogenic Shock Complicating Acute Myocardial Infarction (CRP-SHOCK Trial)
NCT07687017 is registered in ClinicalTrials.gov with Leipzig Heart Science gGmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Selective C-Reactive Protein Apheresis in Cardiogenic Shock Complicating Acute Myocardial Infarction (CRP-SHOCK Trial)
- Lead sponsor
- Leipzig Heart Science gGmbH
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- July 20, 2026
- Completion date
- October 31, 2027
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute myocardial infarction (ami), cardiogenic shock